Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide

Mutations Found in the pncA Gene of Mycobacterium tuberculosis in Clinical Pyrazinamide-resistant Isolates from a Local Region of China

(2013) H Zhang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Kinetics and Inhibition of Nicotinamidase fromMycobacterium tuberculosis

(2010) Derrick R. Seiner et al.   BIOCHEMISTRY

Assessing compound binding to the Eg5 motor domain using a thermal shift assay

(2009) Patricia A. McDonnell et al.   ANALYTICAL BIOCHEMISTRY

Specificity and Mechanism ofAcinetobacter baumaniiNicotinamidase: Implications for Activation of the Front-Line Tuberculosis Drug Pyrazinamide

(2009) Paul���K. Fyfe et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance

(2009) Mirko Zimic et al.   INFECTION GENETICS AND EVOLUTION

Mycobacterium tuberculosis Genotypic Diversity in Pyrazinamide-Resistant Isolates of Iran

(2009) Farahnoosh Doustdar et al.   Microbial Drug Resistance

Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand

(2009) Sushil Pandey et al.   PATHOLOGY

Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis

(2009) Patricia Sheen et al.   TUBERCULOSIS

Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

(2008) P. Jureen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase

(2008) Hua Zhang et al.   FEBS Journal